Limiting paracetamol pack size: Has it worked in the UK?

Clinical Toxicology

Volumn 47, Issue 6, 2009, Pages 536-541

  Bateman, D Nicholas ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Pack size; Paracetamol; Regulation

Indexed keywords

PARACETAMOL; ANALGESIC AGENT;

AUTOMUTILATION; DRUG INTOXICATION; DRUG MARKETING; DRUG PACKAGING; LAW; NOTE; POISON CENTER; POLICY; SUICIDE; UNITED KINGDOM; ARTICLE; CANADA; COMMERCIAL PHENOMENA; DOSE RESPONSE; FEMALE; HUMAN; INTOXICATION; LEGAL ASPECT; LIVER DISEASE; MALE; MORTALITY; STATISTICS; SUICIDE ATTEMPT; SURVIVAL RATE;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; CANADA; COMMERCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG PACKAGING; FEMALE; GREAT BRITAIN; HOSPITAL MORTALITY; HUMANS; LIVER DISEASES; MALE; OVERDOSE; POISON CONTROL CENTERS; POISONING; SUICIDE, ATTEMPTED; SURVIVAL RATE;

EID: 67651171751     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650903093192     Document Type: Note

References (37)

1. Bundesministerium fur Gesundheit. Press Release. www.bmg.bund.de/ cln-117/nn-1168258/SharedDocs/Pressemitteilungen/DE/2009/pm-27- 03-09-2.html?-nnn=true. Accessed 27 March 2009.
2. Federal Register 2009; 74(78):18731. http://www.fda.gov/Advisory- Committees/Calendar/ucm143083.htm
3. FDA. http://www.fda.gov/ohrms/dockets/ac/09/briefing/2009-4429b1- 01-FDA.pdf. Accessed 1 June 2009.
4. Rafnsson SB, Oliver JJ, Elton RA, Bateman DN. Poisons admissions in Edinburgh 1981-2001: agent trends and predictors of hospital readmissions. Hum Exp Toxicol 2007; 26:49-57.
5. Hawton K, Fagg J. Deliberate self-poisoning and self-injury in adolescents. A study of characteristics and trends in Oxford, 1976-1989. J Br J Psychiatry 1992; 161:816-823.
6. O'Loughlin S, Sherwwod J. A 20-year review of trends in deliberate self-harm in a British town, 1981-2000. Soc Psychiatry Psychiatr Epidemiol 2005; 40(6):446-453.
7. Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, Weitzel H. Paracetamol self-poisoning-characteristics, prevention and harm reduction. Br J Psychiatr 1996; 168:43-48.
8. Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, Weitzel H. Why patients choose paracetamol for self-poisoning and their knowledge of its dangers. BMJ 1995; 310:164.
9. Medicines Commission 1997. Statutory Instrument No. 2045, ISBN 0 11 064857 9.
10. Greene SL, Dargan PI, Leman P, Jones AL. Paracetamol availability and recent changes in paracetamol poisoning: is the 1998 legislation limiting availability of paracetamol being followed? Postgrad Med J 2006; 82:520-523.
11. BMJ Group. British National Formulary. London: BMJ Group; 2009.
12. Waring WS, Robinson ODG, Stephen AFL, Dow MA, Pettie JM. Does the patient history predict hepatotoxicity after acute paracetamol overdose? Q J Med 2008; 101:121-125.
13. Selhub J. Public health significance of elevated homocysteine. Food Nutr Bull 2008; 29(2 Suppl.):S116-S125.
14. Futter LE, al-Swayeh AO, Moore PK. A comparison of the effect of nitroparacetamol and paracetamol on liver injury. Br J Pharmacol 2001; 132:10-12.
15. Langman MJ, Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden? Pharmacoepidemiol Drug Saf 2001; 10:13-19.
16. Fosbøl EL, Sørensen R, Folke F, Buch P, Gadsbøll N, Rasmussen S, Poulsen HE, Køber L, Madsen M, Torp-Pedersen C. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009; 169:141-149.
17. Parazella MA. Drug-induced nephropathy: an update. Expert Opin Drug Saf 2005; 4:689-706.
18. Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. Health Technol Assess 2006; 10:1-183.
19. Hawton K, Townsend E, Deeks J, Appleby L, Gunnell D, Bennewith O, Cooper J. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ 2001; 322:1203-1207.
20. Sheen CL, Dillon JF, Bateman DN, Simpson KJ, Macdonald TM. Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen. Pharmacoepidemiol Drug Saf 2002; 11:329-331.
21. Morgan O, Hawkins L, Edwards N, Dargan P. Paracetamol (acetaminophen) pack size restrictions and poisoning severity: time trends in enquiries to a UK poisons centre. J Clin Pharm Ther 2007; 32:449-455.
22. Laing WJ, Gordon LD, Lee DS, Good AM. Have the new pack size regulations impacted on UK paracetamol overdose? Clin Toxicol 2001; 39:301.
23. Bateman DN, Gorman DR, Bain M, Inglis JHC, House FR, Murphy D. Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland. Br J Clin Pharmacol 2006; 62:573-581.
24. Sheen CL, Dillon JF, Bateman DN, Simpson K, MacDonald TM. The effect on toxicity on reducing the size of available paracetamol pack sizes. Gut 2001; 48(Suppl. 1): A105.
25. Hughes B, Durran A, Langford NJ, Mutimer D. Paracetamol poisoning: impact of pack size restrictions. J Clin Pharm Ther 2003; 28:307-310.
26. Prince MI, Thomas SHL, James OFW, Hudson M. Reduction in incidence of severe paracetamol poisoning. Lancet 2000; 355:2047-2049.
27. Newsome PN, Bathgate AJ, Henderson NC, MacGilchrist A, Plevris JN, Masterton G, Garden OJ, Lee A, Hayes PC, Simpson KJ. Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland. Lancet 2001; 358:1612-1613.
28. Sandilands EA, Bateman DN. Co-proxamol withdrawal has reduced suicide from drugs in Scotland. Br J Clin Pharmacol 2008; 66:290-293.
29. Morgan OW, Griffiths C, Majeed A. Interrupted timeseries analysis of regulations to reduce paracetamol (acetaminophen) poisoning. PloS Med 2007; 4(4):e105.
30. Pakravan N, Simpson KJ, Waring WS, Bates CM, Bateman DN. Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. Eur J Clin Pharmacol 2009; 65:163-168.
31. Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, Arundel M, Bernal W, Gunson B, Hudson M, Suri D, Simpson K. UK legislation on analgesic packs: before and after study of long-term effect on poisonings. Br Med J 2004; 329:1076.
32. Prior M, Cooper K, Cummins P, Bowen D. Acetaminophen availability increases in Canada with no increase in the incidence of reports of inpatient hospitalizations with acetaminophen overdose and acute liver toxicity. Am J Ther 2004; 11:443-452.
33. Gorman DR, Bain M, Inglis JCH, Murphy D, Bateman DN. How has legislation restricting paracetamol pack size affected patterns of deprivation related inequalities in self-harm in Scotland? Public Health 2007; 121:45-50.
34. Payne RA, Oliver JJ, Bain M, Elders A, Bateman DN. Patterns and predictors of re-admission to hospital with self-poisoning in Scotland. Public Health 2009; 123:134-137.
35. Fosnocht D, Taylor JR, Caravati EM. Emergency department patient knowledge concerning acetaminophen (paracetamol) in over-thecounter and prescription analgesics. Emerg Med J 2008; 25:213-216.
36. Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006; 15:398-405.
37. Beer C, Pakravan K, Hudson M, Smith LT, Simpson K, Bateman DN, Thomas SHL. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. Quart J Med 2007; 100:93-96.